Skip to main content

Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

Talking Therapeutics
11/04/2023
In this week’s issue, we discuss the ACORN study, which compared the outcomes of cefepime vs pip-tazo in patients with hospital-acquired infections.
In this week’s issue, we discuss the ACORN study, which compared the outcomes of cefepime vs pip-tazo in patients with hospital-acquired infections.
In this week’s issue, we discuss...
11/04/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
12/21/2022
Dr Jennings walks through findings from a new study comparing 2 dosing regimens of mycophenolate mofetil in patients who had heart transplant surgery.
Dr Jennings walks through findings from a new study comparing 2 dosing regimens of mycophenolate mofetil in patients who had heart transplant surgery.
Dr Jennings walks through...
12/21/2022
Pharmacy Learning Network
douglas jennings
Commentary
10/07/2021
“As the number of HIV treatment options have burgeoned and patient management has democratized well beyond HIV specialists into fields such as primary and family care, clinicians are compelled to remain abreast of key practice updates,” says...
“As the number of HIV treatment options have burgeoned and patient management has democratized well beyond HIV specialists into fields such as primary and family care, clinicians are compelled to remain abreast of key practice updates,” says...
“As the number of HIV treatment...
10/07/2021
First Report Managed Care
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
06/02/2022
In the newest installment of Talking Therapeutics, Dr Jennings shares research into whether electronic health record alerts can improve the prescription of medical therapy.
In the newest installment of Talking Therapeutics, Dr Jennings shares research into whether electronic health record alerts can improve the prescription of medical therapy.
In the newest installment of...
06/02/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
03/16/2023
Dr Jennings continues his recap of ACC.23 in this week’s issue of Talking Therapeutics, highlighting data from 2 trials focused on a new PSCK9 inhibitor and anticoagulation in patients with COVID-19.
Dr Jennings continues his recap of ACC.23 in this week’s issue of Talking Therapeutics, highlighting data from 2 trials focused on a new PSCK9 inhibitor and anticoagulation in patients with COVID-19.
Dr Jennings continues his recap...
03/16/2023
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
02/09/2024
In this installment of Talking Therapeutics, Dr Jennings explores the cardiovascular advantages associated with plant-based diets. He delves into research findings supporting this assertion and shares practical recommendations for patients...
In this installment of Talking Therapeutics, Dr Jennings explores the cardiovascular advantages associated with plant-based diets. He delves into research findings supporting this assertion and shares practical recommendations for patients...
In this installment of Talking...
02/09/2024
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
07/07/2021
Dr Jennings discusses the latest updates in diabetes care for this week’s edition of Talking Therapeutics—highlighting data from the American Diabetes Association’s annual Scientific Sessions.
Dr Jennings discusses the latest updates in diabetes care for this week’s edition of Talking Therapeutics—highlighting data from the American Diabetes Association’s annual Scientific Sessions.
Dr Jennings discusses the latest...
07/07/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
12/29/2021
Dr Jennings wraps up 2021, reviewing this year's Talking Therapeutics installments and inviting readers to leave feedback on what topics to cover in 2022.
Dr Jennings wraps up 2021, reviewing this year's Talking Therapeutics installments and inviting readers to leave feedback on what topics to cover in 2022.
Dr Jennings wraps up 2021,...
12/29/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
09/02/2022
In the latest installment of Talking Therapeutics, Dr Jennings shares new data on SGLT2 inhibitors and diuretics presented at this year's European Society of Cardiology meeting.
In the latest installment of Talking Therapeutics, Dr Jennings shares new data on SGLT2 inhibitors and diuretics presented at this year's European Society of Cardiology meeting.
In the latest installment of...
09/02/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
06/16/2023
In the latest installment of Talking Therapeutics, Dr Jennings discusses the impact of SGLT2 inhibitors on ischemic stroke in patients with atrial fibrillation and emphasizes the need for further research.
In the latest installment of Talking Therapeutics, Dr Jennings discusses the impact of SGLT2 inhibitors on ischemic stroke in patients with atrial fibrillation and emphasizes the need for further research.
In the latest installment of...
06/16/2023
Pharmacy Learning Network